|
| Main | | |
| Brand Name | Cervarix |
| Mechanism | Gardasil protects against genital warts, whereas Cervarix does not. |
| Competition | MRK's Gardasil received strong recommendation from ACIP |
| Timeline | Filed in EU in March 2006. Gardasil filed in EU in December 2005. |
| | Approved in the US 10/16/2009, versus Gardasil in 10/2006. Suffered approvable letter 12/2007. Filed 4/2007. |
| | Approved in Japan 10/16/2009, ahead of Gardasil. |
| Clinical Trials | |
| | Phase III 008 "PATRICIA" study n=18,644 published in Lancet. |
| | Interim analysis showed 79.5% coverage against persistent infections? |
| | 92% versus 51.9% CIN2+ with HPV31, 33 and 45. 100% in ATP-E (all three doses). |
| | |
| | Head-to-Head vs Gardasil |
| | n=1042, data expected in 2008 |